Key result
Extracorporeal membrane oxygenation in patients with pheochromocytoma crisis was associated with similar 90-day mortality compared to management without it (22% vs 30%, p=0.7).
Why the study?
Does extracorporeal membrane oxygenation improve survival in patients with pheochromocytoma crisis in the ICU?
Cohort (n=34)
Yes
Does extracorporeal membrane oxygenation improve survival in patients with pheochromocytoma crisis in the ICU?
Pheochromocytoma crisis in the ICU is associated with high mortality (27% at 90 days), and rescue ECMO may be a viable therapeutic option in severe cases despite no statistically significant mortality difference in this small cohort.
Similar mortality with ECMO does not support routine use; leaves open its role in refractory pheochromocytoma crisis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sauneuf et al. (2017) conducted a cohort in Pheochromocytoma crisis (n=34). Extracorporeal membrane oxygenation vs. Management without extracorporeal membrane oxygenation was evaluated on 90-day mortality (p=0.7). Extracorporeal membrane oxygenation in patients with pheochromocytoma crisis was associated with similar 90-day mortality compared to management without it (22% vs 30%, p=0.7).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: